$3.60 $0.01 (0.3%)

04:15 PM EDT on 08/04/20

Protalix Biotherapeutics Inc (NYSEMKT:PLX)

CAPS Rating: No stars

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system.

Current Price $3.60 Mkt Cap $115.8M
Open $3.57 P/E Ratio 0.00
Prev. Close $3.57 Div. (Yield) $0.00 (0.0%)
Daily Range $3.54 - $3.60 Volume 720
52-Wk Range $1.70 - $4.87 Avg. Daily Vol. 169,670

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

148 Outperform
72 Underperform
 

All-Star Players

15 Outperform
22 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSEMKT:PLX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Paul8888888 (< 20)
Submitted January 23, 2016

It is outperforming the market. Volume low. Nobody is panicking.

TMFBiologyFool (72.79)
Submitted May 02, 2012

Low patient numbers + 2 competitors = tough launch.I actually like the manufacturing technology, but next drug is still years away.

NYSEMKT:PLX VS S&P 500 (SPY)

Fools bullish on NYSEMKT:PLX are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about PLX.

Recs

1
Member Avatar Paul8888888 (< 20) Submitted: 1/23/2016 2:31:12 PM : Outperform Start Price: $0.86 NYSE MKT:PLX Score: +242.27

It is outperforming the market. Volume low. Nobody is panicking.

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 11/5/2013 2:56:24 PM : Outperform Start Price: $4.40 NYSE MKT:PLX Score: -105.33

IHS pattern

Recs

1
Member Avatar TMFBiologyFool (72.79) Submitted: 5/2/2012 12:24:24 PM : Underperform Start Price: $7.02 NYSE MKT:PLX Score: +184.21

Low patient numbers + 2 competitors = tough launch.

I actually like the manufacturing technology, but next drug is still years away.

Leaderboard

Find the members with the highest scoring picks in PLX.

Score Leader

midastouch017

midastouch017 (44.03) Score: +804.35

For those who believe the biosimilar sector will enjoy a robust bright future, PLX is a wise bet

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
beecha 22.65 9/19/2017 Outperform 5Y $0.60 +496.35% +32.02% +464.32 0 Comment
portefeuille3 97.43 12/27/2017 Outperform 5Y $0.66 +445.43% +23.41% +422.02 0 Comment
Spelunkin 95.41 11/3/2009 Underperform 5Y $10.39 -65.45% +218.16% +283.61 0 Comment
anticitrademix2 < 20 11/2/2009 Underperform 5Y $9.90 -63.74% +216.97% +280.71 0 Comment
anticitrademix < 20 11/2/2009 Underperform 5Y $9.90 -63.74% +216.97% +280.71 0 Comment
TrackDuality 25.55 11/6/2009 Underperform 5Y $11.89 -69.81% +210.62% +280.42 0 Comment
MSFOBV1YH 99.26 11/4/2009 Underperform 5Y $10.93 -67.15% +212.82% +279.98 0 Comment
ModernDayWarrior 38.08 10/29/2009 Underperform 5Y $9.58 -62.53% +213.78% +276.30 0 Comment
39272x4 26.36 11/9/2009 Underperform 5Y $12.00 -70.08% +205.75% +275.84 0 Comment
mathieugp 25.57 9/28/2009 Underperform 3M $7.87 -54.38% +214.79% +269.18 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PLX.